I am not saying that curing the common cold would not be incredibly valuable to society, but responding to the OP who was suggesting that since we have a treatm

I am not saying that curing the common cold would not be incredibly valuable to society, but responding to the OP who was suggesting that since we have a treatment for HepC we can have one for the common cold. The pharma companies look at what insurance companies will pay for and develop drugs and vaccines that they will pay for. The insurance companies know the cost to their bottom line of hepC and they know the cost of the common cold.